Skip to main content
. 2024 May 16;43(9):831–840. doi: 10.1097/INF.0000000000004382

TABLE 3.

Pathogen Detection and Laboratory Values by Age Groups

Patient Age 0–4 Years n = 32 5–10 Years n = 37 ≥11 Years n = 33 Total n = 102
Pathogen detection
Blood culture
 N positive/N specimens (% positivity rate) 8/29 (28%) 21/35 (60%) 26/30 (87%) 55/94 (59%)
 Pathogen (% of all positive cultures) S. aureus: n = 4 (50%)
S. pyogenes: n = 2 (25%)
S. pneumoniae: n = 1
Micrococcus luteus: n = 1
S. aureus: n = 11 (52%)
S. pyogenes: n = 9 (43%)
Salmonella Gr. D: n = 1
S. aureus: n = 20 (77%)
E. coli: n = 3 (12%)
S. pyogenes: n = 1
Others: n = 2*
S. aureus: n = 35 (64%)
S. pyogenes: n = 12 (22%)
E. coli: n = 3 (6%)
Others: n = 5 (11%)
Tissue culture
 N positive/N specimen (% positivity rate) 17/21 (81%) 18/20 (90%) 16/18 (89%) 51/59 (86%)
 Pathogen (% of all positive cultures) S. pyogenes: n = 6 (35%)
Kingella kingae: n = 6 (35%)
S. pneumoniae: n = 2 (12%)
S. aureus: n = 2 (12%)
Others: n = 1 (6%)
S. aureus: n = 9§ (50%)
S. pyogenes: n = 7 (39%)
Enterobacter spp.: n = 1 (5%)
Others: n = 1 (5%)
S. aureus: n = 9 (56%)
E. coli: n = 3 (19%)
S. pneumoniae: n = 2 (13%)
S. pyogenes: n = 1 (6%)
S. lugdunensis: n = 1(6%)
S. aureus: n = 20§ (39%)
S. pyogenes: n = 14 (27%)
Kingella kingae: n = 6 (12%)
S. pneumoniae: n = 4 (8%)
Others: n = 7 (14%)
Any
 N patients with any positive (% of all patients) 21 (66%) 30 (82%) 32 (97%) 83 (81%)
 Pathogen (% of all positive cultures) S. pyogenes: n = 7 (33%)
Kingella kingae: n = 6 (29%)
S. aureus: n = 5 (24%)
S. pneumoniae: n = 2 (10%)
Others: n = 1 (5%)
S. aureus: n = 16 (53%)
S. pyogenes: n = 11 (37%)
Others: n = 3 (10%)
S. aureus: n = 21 (66%)
E. coli: n = 4 (13%)
S. pyogenes: n = 2 (6%)
S. pneumoniae: n = 2 (6%)
Others: n = 3 (9%)
S. aureus: n = 42 (51%)
S. pyogenes: n = 20 (24%)
Kingella kingae: n = 6 (7%)
S. pneumoniae: n = 4 (5%)
E. coli: n = 4 (5%)
Others: n = 7 (8%)
Laboratory values
WBC
 N patients with ≥1 done (% of all patients)

32 (100%)

37 (100%)

32 (97%)

101 (99%)
 Baseline mean WBC on admission (×109/L), median [IQR] 17.7 [12.9–23.2] 14.4 [9.8–18.6] 10.25 [7–14.4] 13.95 [8.9–19.4]
 Maximal mean WBC value (×109/L), median [IQR] 17.7 [13.8–23.2] 15.5 [10.6–20.1] 12.4 [9.5–18.3] 15.8 [10.7–19.9]
CRP
 N patients with ≥1 done (% of all patients)

32 (100%)

37 (100%)

33 (100%)

102 (100%)
 Baseline mean CRP on admission (mg/L), median [IQR] 71 [51–129] 97 [52–155] 100 [44–152] 90 [50.3–149.3]
 Maximal mean CRP (mg/L), median [IQR] 99.5 [65.2–147.8] 129 [78–221] 162 [84–213.1] 130.5 [71.3–190.8]
ESR
 N patients with ≥1 done (% of all patients)

22 (69%)

26 (70%)

24 (72%)

72 (71%)
 Baseline mean ESR on admission(mm/h), median [IQR] 63.5 [47–83.75] 53.5 [35–67.8] 36 [17.75–60.75] 52.5 [27.3–68.3]
Maximal mean ESR value (mm/h), median [IQR] 67 [48–85] 52 [36–74] 48.5 [26.3–84] 57.5 [35–84.5]
*

Others: Concomitant Candida parapsilosis and Enterococcus spp. (n = 1); polymicrobial infection (self-contaminated peripherally inserted central catheter line; n = 1).

Abscess puncture plus PCR positive throat swab (n = 2), joint puncture plus PCR positive throat swab (n = 1); PCR positive throat swabs only (n = 3; see Methods section).

Others: Streptococcus agalactiae (n = 1).

§

Concomitant Klebsiella pneumoniae isolation from tissue culture in one patient.

Others: Group C streptococcus.